NCT02571634View on ClinicalTrials.gov

Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Minor Procedural Pain
Interventions
DRUG

Lazanda

Given pre radiofrequency ablation of the lumbar facet joints to see if patients can remain alert, and it provides relaxation and pain control.

Trial Locations (1)

28310

Womack Army Medical Center, Fort Bragg

Sponsors

Collaborators (1)

Depomed
All Listed Sponsors
collaborator

Depomed

INDUSTRY

lead

Defense and Veterans Center for Integrative Pain Management

OTHER

NCT02571634 - Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints | Biotech Hunter | Biotech Hunter